Narendra Agrawal

12PUBLICATIONS
23CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or Deeper.

|Apr 27, 2026
Experience with Anthracycline Free Intensive Regimen BE_CODD for Managing a Case of Advanced Classical Hodgkin Lymphoma (CHL).

|Mar 04, 2025
Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.

Varsha Mishra, Pratibha Singh Yadav, Reema Singh

|Sep 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India.

Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak

|Dec 04, 2023
Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant.

Pallavi Mehta, Aakanksha Singh, Rohan Halder

|Sep 22, 2023
Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical hodgkin's lymphoma and primary mediastinal B cell lymphoma.

Tribikram Panda, Sujay Rainchwar, Rohan Halder

Pageof 2

Frequent Collaborators

5 joint publications

Dinesh Bhurani

4 joint publications

Reema Singh

3 joint publications

Jyotsna Kapoor

2 joint publications

Prasanth Ganesan